Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...
Pfizer said a mid-stage study of its investigational CDK4 inhibitor atirmociclib met its key goal in certain patients with breast cancer. Pfizer on Tuesday said the randomized Phase 2 study met its ...
Pfizer has a lofty goal for the CDK4 inhibitor atirmociclib, the New York pharma’s answer to Ibrance’s loss of patent protection next year. In 2025, Ibrance led Pfizer’s oncology portfolio with $1.04 ...
ARLINGTON, Va.--(BUSINESS WIRE)--Today, Venture Global, Inc. (NYSE: VG) is announcing a final investment decision (FID) and successful closing of an $8.6 billion project financing for the second phase ...
Space.com on MSN
NASA's Artemis 2 moon launch may be visible from Florida and Georgia today. Here's when to look
NASA's historic Artemis 2 moon mission is set to launch on April 1, and skywatchers in Florida and Georgia may get to see the ...
Here's everything we know about Marvel Phase 6 ...
Jujutsu Kaisen Season 4 (Culling Game Part 2) is officially announced as the story continues after an intense Season 3 finale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results